DELIVERY ORDER
Active36C25627N0040
Department of Veterans Affairs › 256-NETWORK CONTRACT OFFICE 16 (36C256)
$1.3M
obligated · signed 6 days ago
MEDVAMC FSS ORDER PYLARIFY F18 | PROGENICS PHARMA
Performance timeline
Start
Oct 1, 2026
Current end
Sep 30, 2027
Potential end
Sep 30, 2031
with all options
Loading status
Estimated start: Sep 30, 2030
PROGENICS PHARMACEUTICALS INC
Contract 36C25627N0040
UEI
YLYKVRPCTCR3
Parent Company
LANTHEUS HOLDINGS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$1,299,139
Base + Exercised Options
$1,299,139
Total Ceiling Value
$6,495,696
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 03
Awarding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
256-NETWORK CONTRACT OFFICE 16 (36C256)
Office
Funding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
580-HOUSTON(00580)
Office
Contract Vehicle
36F79725D0093
FSSDepartment of Veterans Affairs
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.